We are passionate about cell biology
and leverage our unique cell metabolism and AI-powered data analysis platforms
to shorten the time to critical insights and improve human health
Our products
We are experts in single-cell analysis, metabolism, and AI
Proper metabolism is key for cell fate and function in the body.
Our unique IVD and cell therapy reagents allow monitoring pf cellular fitness and metabolism.
We leverage our proprietary platform to decipher single cell metabolic programs. In addition, we help clinicians infer clinical outcomes of disease from our In vitro diagnostics, and improve optimization of cell therapy products.
METAflow is the only software
able to offer an “augmented intelligence” solution allowing users to get quick, objective and reproducible results.
A highly differentiated approach to modern flow- and mass-cytometry analysis, for use in research and clinical diagnostics.
Meet our team
A multidisciplinary team of Entrepreneurs, Biologists, Data Scientists, and expert Mathematicians
from 12 nationalities, based in Paris, France, and the USA
Our latest news
June 23, 2023June 23-24, 2023 – 15th Congress of the European Paediatric Neurology Society (EPNS)
June 9, 2023AP-HP talks about our test METAglut1, simple and fast, allowing the early testing for any type of phenotype
May 3, 20232023 – METAglut1 Recommended for Coverage by HAS
March 13, 20232023 – METAFORA in the USA
September 15, 2022METAFORA on stage at ESCCA – 22-24 Sept 2022
April 7, 2022METAglut1 Story time: Domitille Gras testimony
March 29, 202248th SENP Lausanne
February 7, 202231st SFNP Congress
September 16, 2021Sebia and METAFORA biosystems form strategic partnership to develop advanced in vitro diagnostics
July 20, 2021Feedback from 3rd European GLUT1D conference
June 21, 20213rd European GLUT1D conference
June 21, 2021Quality Management System certification based on the international standard NF EN ISO 13485:2016
June 21, 2021Last inclusion of a patient in METAglut1 validation study
June 21, 2021First inclusion of a retrospective patient in the validation study of the METAglut1™ test in Germany
June 21, 2021Toulouse, 30th Annual Meeting of the “ Société Française de Neurologie Pédiatrique ” (SFNP)
June 21, 2021Washington, 8th Biennial Conference of the Glut1 Deficiency Foundation
June 21, 2021Scientific publication
June 21, 2021Strasbourg, 29th Annual Meeting of the ” Société Française de Neurologie Pédiatrique ” (SFNP)
June 21, 2021Paris, 47th Annual Meeting of the “ Société Européenne de Neurologie Pédiatrique ” (SENP)
June 21, 2021Dietmar Hopp Metabolic Center is now equipped with METAglut1 test to conduct a validation study in Germany
September 24, 2018First patient inclusion of the METAglut1 study
July 13, 20182nd European Conference on Glut1 Deficiency- Matthews Friends, 22nd-23rd June 2018, Grinstead, UK
June 23, 2018SNEP 2018, 27-28 April, Barcelone
July 13, 2017Metafora Biosystems visiting Nashville
June 19, 2017METAFORA and collaborators publishes a paper in Annals of Neurology
February 15, 2017METAglut1 gets CE marked
February 7, 2017Our innovative technology becomes available for patients
November 25, 2016Metafora at Actionaria
November 10, 2016METAFORA to attend the Actionaria event
November 7, 2016Our Partnership with Cerba HealthCare
October 25, 2016First European event on GLUT1 Deficiency
October 24, 2016New scientific board
April 16, 2016Vincent Petit, METAFORA’s CEO, gives an interview
April 12, 2016Naomi Taylor’s research group publish new result using METAFORA’s technology
April 1, 2016Laurent Yvan-Charvet’s research team publish new result using METAFORA’s technology
March 15, 2016David Finlay’s research group publish new result using METAFORA’s technology
February 10, 2016METAFORA is one of the top 20 French start-up Big Booster attend bootcamp in Boston
October 30, 2015METAFORA biosystems is one of the 20 start-up selected for next Big Booster’s Boot camp in Boston!
October 7, 2015RBDs revealed a metabolic stress induced by statins in muscle cells
July 6, 2015Strategic plans of the company
Our achievements
February 2024
METAglut1™ obtains universal national coverage
in France as recommended by the
French National Authority for Health
(Haute Autorité de Santé, HAS)July 2023
Showcase of early version of
METAflow for research
October 2022
Laureate of EIC (European Innovation Council) accelerator program to develop METAflow™
for clinical applications
June 2021
Partnership with Sebia to develop innovative IVDs (In Vitro Diagnositics)
for Hemato-OncologyJanuary 2019
Winner of the Innovation Prize from Bpifrance
to develop the METAbolism platform
for diagnostics in OncologyJune 2018
Laureate of H2020 Innovation Grant
to fund METAglut1™ 's validation studyMarch 2018
METAglut1™ obtains the Forfait Innovation
(fast track reimbursement program)
after its CE-Marking in 2017
Our worldwide partnerships
At METAFORA, we are building an ecosystem to ensure that our solutions meet expectations.
Patient associations help us to deeply understand unmet needs, when leading medical researchers collaborate with us to develop and validate our solutions. We are grateful to many institutions for their continuous support and we are also working hard to extend our collaborations to make our solutions available for daily clinical practice.
Patient associations
Research collaborations
Supporting organizations
Partnerships
Contact us
METAFORA Biosystems
Pépinière Paris Biotech Santé
29 rue du Faubourg Saint Jacques
75014 Paris, FRANCE
METAFORA biosystems, Inc.
Suite 417
100 South State Street
IL 60603, Chicago, USA
For any request, or if you would like to join the team, do not hesitate to contact us via
